000 | 03036nam a22004935i 4500 | ||
---|---|---|---|
001 | u375120 | ||
003 | SIRSI | ||
005 | 20160812084308.0 | ||
007 | cr nn 008mamaa | ||
008 | 110414s2011 gw | s |||| 0|eng d | ||
020 |
_a9783642157424 _9978-3-642-15742-4 |
||
040 | _cMX-MeUAM | ||
050 | 4 | _aRC86-88.9 | |
082 | 0 | 4 |
_a616.028 _223 |
100 | 1 |
_aAzoulay, Elie. _eeditor. |
|
245 | 1 | 0 |
_aPulmonary Involvement in Patients with Hematological Malignancies _h[recurso electrónico] / _cedited by Elie Azoulay. |
264 | 1 |
_aBerlin, Heidelberg : _bSpringer Berlin Heidelberg, _c2011. |
|
300 |
_aXIX, 827 p. 161 illus., 63 illus. in color. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _aPreamble and Introduction.-Epidemiology -- Diagnostic Strategy in Hematologic Malignancies Patients -- Lung Infections in Patients with Hematologic Malignancies.-Noninfectious Pulmonary Involvement in Patients with Hematologic Malignancies -- Treatment and Difficult Decisions in Patients with Hematologic Malignancies.-Pearls that You Should be Aware of.-Post Face. | |
520 | _aThe number of patients treated for hematological malignancies is increasing steadily. To obtain the highest possible cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially; however, this has been achieved at the price of life-threatening toxic and infectious complications that chiefly target the lung. This book provides clinicians caring for patients with hematological malignancies with detailed, up-to-date information on all relevant aspects of pulmonary involvement. Individual sections are devoted to epidemiology, diagnostic strategy, lung infections, non-infectious pulmonary involvement, and treatment, including decision making in patients with acute respiratory failure. Each of these sections contains a number of chapters, all written by leading international experts. In addition, the reader’s attention is drawn to important "pearls" relating to each condition. | ||
650 | 0 | _aMedicine. | |
650 | 0 | _aCritical care medicine. | |
650 | 0 | _aHematology. | |
650 | 0 | _aEmerging infectious diseases. | |
650 | 0 | _aPneumology. | |
650 | 0 | _aOncology. | |
650 | 1 | 4 | _aMedicine & Public Health. |
650 | 2 | 4 | _aIntensive / Critical Care Medicine. |
650 | 2 | 4 | _aHematology. |
650 | 2 | 4 | _aOncology. |
650 | 2 | 4 | _aInfectious Diseases. |
650 | 2 | 4 | _aPneumology/Respiratory System. |
710 | 2 | _aSpringerLink (Online service) | |
773 | 0 | _tSpringer eBooks | |
776 | 0 | 8 |
_iPrinted edition: _z9783642157417 |
856 | 4 | 0 |
_zLibro electrónico _uhttp://148.231.10.114:2048/login?url=http://link.springer.com/book/10.1007/978-3-642-15742-4 |
596 | _a19 | ||
942 | _cLIBRO_ELEC | ||
999 |
_c203000 _d203000 |